We have observed
3 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after October 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Pharmaceutical composition comprising lacosamide and levetiracetam for use in the treatment of epilepsy
Pharmaceutical composition comprising lacosamide and levetiracetam
PHARMACEUTICAL COMPOSITION COMPRISING BRIVARACETAM AND LACOSAMIDE WITH SYNERGISTIC ANTICONVULSANT EFFECT